Eric Ryszkiewicz, Outcomes Analyst, Clinical Business Analytics, Palo Alto Medical Foundation - Data Science Invited Talk Series
Data Science Invited Talk Series
Speaker: Eric Ryszkiewicz, Outcomes Analyst, Clinical Business Analytics, Palo Alto Medical Foundation
Where: Lindley Hall, Room 102
When: Friday - March 31, 2017 1:30 PM
Topic: Data Science Applications in Healthcare: Improving Access, Performance, and Resource Deployment
Abstract: Large healthcare systems collect a wealth of data related to nearly all contact with patients, yet frequently struggle with the translation into useful knowledge. As organizations shift away from a model of fee-for-service and towards a new paradigm of accountable care, it will be increasingly important that they can a.) preserve or improve access for patients, and b.) assess performance on scales from the individual physician up to the entire system. Problems involving missing data, forecasts of operations or performance, and the added value of partnering with nearby institutions all present opportunities for the application of novel solutions to some of the most challenging issues in the contemporary healthcare environment. In this talk, Eric will outline current efforts at PAMF to model and forecast access in primary and specialty care, as well as assess the performance of surgeons and hospitalists operating in local hospitals. He’ll also discuss forecasting performed on behalf of a major solid organ transplant center in attempts to assure regulatory compliance and outperform the competition on standard metrics.
Bio: Eric Ryszkiewicz, MS MPH is an Outcomes Analyst at Palo Alto Medical Foundation (PAMF), and serves as the Predictive Analytics and Data Science lead for PAMF’s Division of Clinical Business Analytics. His academic background has included healthy doses of chemical engineering, epidemiology, and biostatistics, with a strong focus on applied research. Other professional experience over the past 15 years has included roles as varied as cell fermentation process development in the pharmaceutical industry, air quality monitoring for both research and regulatory purposes, and quality management in solid organ transplantation.